Method for stimulating weight loss and/or for lowering triglycerides in patients

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7504435
APP PUB NO 20080146668A1
SERIAL NO

11104900

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Administration of a therapeutically effective amount of 3,5-diiodothyropropionic acid stimulates weight loss in patients, lowers triglyceride levels and reduces risk of death or progression of coronary heart disease in patients with metabolic syndrome.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONATUCSON, AZ302
THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA ("UA")TUCSON, AZ0
THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS ("DVA")WASHINGTON, DC0

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Goldman, Steven Tucson, US 7 86
Morkin, Eugene - 6 20

Cited Art Landscape

Patent Info (Count) # Cites Year
 
BTG INTERNATIONAL INC. (1)
* 5158978 Thyroid hormone treatment of acute cardiovascular compromise 30 1991
 
SYNGENTA LIMITED (1)
4977148 Amide derivatives 27 1990
 
SYNTEX (U.S.A.) INC. (1)
5284971 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents 34 1992
 
KOO, CATHERINE, DR (1)
6221911 Uses for thyroid hormone compounds or thyroid hormone-like compounds 19 1998
 
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1)
5883294 Selective thyroid hormone analogs 15 1997
 
BRISTOL-MYERS SQUIBB COMPANY (1)
6951844 Phenyl naphthol ligands for thyroid hormone receptor 10 2004
 
JOHN WYETH & BROTHER LIMITED (1)
4451465 Anti-obesity agents 4 1982
 
THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (1)
6716877 Method to treat chronic heart failure and/or elevated cholesterol levels 3 2003
 
Octamer, Inc. (1)
6017958 Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity 12 1997
 
IMPERIAL CHEMICAL INDUSTRIES PLC (1)
4999377 Chemical compounds 16 1989
 
ZENECA LIMITED (1)
4772631 Phenyl ethers 48 1986
 
Southern Arizona Veterans Affairs Health Care System (1)
6534676 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same 6 2001
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

  • No Forward Cites to Display

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 17, 2020
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00